# Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome

> **NCT07711964** · PHASE4 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)

## Interventions

- **OTHER:** No steroids (Arm A)
- **DRUG:** Corticosteroids, low dose for 10 days
- **DRUG:** Corticosteroids, low dose for 7 days
- **DRUG:** Corticosteroids, medium dose for 10 days
- **DRUG:** Corticosteroids, medium dose for 7 days
- **OTHER:** No steroids (Arm B)

## Key facts

- **NCT ID:** NCT07711964
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2030-04-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711964, "Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07711964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*